The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_002755.3(MAP2K1):c.364A>G (p.Asn122Asp)

CA10576999

228273 (ClinVar)

Gene: MAP2K1
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: e13f1eb9-0fbc-4e6c-96cf-d06a0b166fca
Approved on: 2020-03-16
Published on: 2020-03-24

HGVS expressions

NM_002755.3:c.364A>G
NM_002755.3(MAP2K1):c.364A>G (p.Asn122Asp)
NC_000015.10:g.66436818A>G
CM000677.2:g.66436818A>G
NC_000015.9:g.66729156A>G
CM000677.1:g.66729156A>G
NC_000015.8:g.64516210A>G
NG_008305.1:g.54946A>G
NM_002755.4:c.364A>G
ENST00000307102.9:c.364A>G
ENST00000425818.2:n.875A>G
More

Pathogenic

Met criteria codes 4
PM2 PP2 PS4_Supporting PS2_Very Strong

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.364A>G (p.Asn122Asp) variant in MAP2K1 was absent from gnomAD (PM2). It has been observed in 3 probands with clinical features of a RASopathy, including 1 de novo occurrence with maternity and paternity confirmed and 2 assumed de novo occurrences (PM2_VS; SCV000271240.2; Otto-von-Guericke-Universität Magdeburg internal communication; Invitae internal data, SCV000947966.1). Of these patients, 2 received a clinical diagnosis of either Noonan syndrome or cardiofaciocutaneous syndrome (PS4_Supporting). Of note, this variant was observed in 1 proband without clinical information who inherited it from a parent with unknown clinical status (GeneDx internal data). The c.364A>G (p.Asm122Asp) variant is located in MAP2K1, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant RASopathy based on RASopathy-specific ACMG/AMP criteria (PMID:29493581): PS2_VS, PS4_Supporting, PM2, PP2.
Met criteria codes
PM2
Absent from gnomAD.
PP2
MAP2K1 is a missense-constrained gene.
PS4_Supporting
Otto-von-Guericke-Universität Magdeburg internal communication: Observed in a child with CFC, assumed de novo without parentage confirmed LMM: 6 week old male with features of NS de novo w/o parentage confirmation (SCV000271240.2)
PS2_Very Strong
This variant was observed as an assumed de novo occurrence without parentage confirmed in 2 cases (LMM internal data, SCV000271240.2; Otto-von-Guericke-Universität Magdeburg internal communication). It was also observed de novo in one case with features of a RASopathy with confirmed paternity and maternity (SCV000947966.1).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.